Xinzheng Dai

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0001-9199-2073

发表论文 35 篇 · 总被引 1316 次 · h-index 20

代表论文

• Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma (2023 · Journal of Hepatology · 被引 153)
• Hypomethylation‐mediated activation of cancer/testis antigen KK‐LC‐1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling (2019 · Cell Proliferation · 被引 76)
• Emerging mechanisms progress of colorectal cancer liver metastasis (2022 · Frontiers in Endocrinology · 被引 64)
• 5‐Hydroxytryptamine Receptor 1D Aggravates Hepatocellular Carcinoma Progression Through FoxO6 in AKT‐Dependent and Independent Manners (2018 · Hepatology · 被引 57)
• Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners (2023 · Cell Metabolism · 被引 53)
• Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study (2022 · Frontiers in Oncology · 被引 48)